期刊文献+

Caprini风险评估模型筛选老年急性心力衰竭患者静脉血栓栓塞症的有效性分析 被引量:6

Validity of caprini risk assessment modle for venous thromboembolism in elderly patients with acute heart failure
下载PDF
导出
摘要 目的分析Caprini风险评估模型筛选老年急性心力衰竭患者静脉血栓栓塞症(venous thromboembolism,VTE)的价值。方法回顾性收集2017年6月至2020年12月首都医科大学附属北京世纪坛医院心内科收治的老年急性心力衰竭合并VTE患者50例作为VTE组,选择同期未患VTE的老年急性心力衰竭患者100例作为对照组,收集所有患者的相关临床资料并根据Caprini风险评估模型对所有患者进行评分及危险度分级,探讨不同危险度分级与老年急性心力衰竭患者VTE形成风险的关系,采用Logistic回归分析老年急性心力衰竭患者发生VTE的主要危险因素。结果VTE组的Caprini评分明显高于对照组,差异有统计学意义[(7.92±2.17)分vs(5.50±1.83)分,P=0.001];老年急性心力衰竭患者极高危组发生VTE的风险是高危组的22.014倍(95%CI=2.907~166.736,P=0.003)。多因素Logistic回归分析显示,卧床>3 d(OR=7.000,95%CI=2.515~19.483,P=0.001)、肺功能异常(OR=3.678,95%CI=1.014~13.346,P=0.048)及D-二聚体升高(OR=1.001,95%CI=1.000~1.002,P=0.019)是老年急性心力衰竭患者发生VTE的独立危险因素。结论Caprini风险评估模型可有效用于评估老年急性心力衰竭患者静脉血栓栓塞症的风险。 Objective To analyze the effectiveness of the Caprini risk assessment model for venous thromboembolism(VTE)in elderly patients with acute heart failure.Methods A total of 50 elderly acute heart failure patients with VTE who were treated in the Department of Cardiology,Beijing Shijitan Hospital,Capital Medical University,were collected retrospectively from June 2017 to December 2020 as the VTE group,and 100 elderly acute heart failure patients who did not suffer from VTE during the same period were selected as the control group.The relevant clinical data of all patients were collected retrospectively,and the risks of all patients were scored and graded by the Caprini risk assessment model to explore the relationship between degree classification and the risk of VTE in elderly patients with acute heart failure.Logistic regression was used to analyze the main risk factors for VTE in elderly patients with acute heart failure.Results The Caprini score of the VTE group was significantly higher than that of the control group,and the difference was statistically significant(7.92±2.17 vs 5.50±1.83,P=0.001).The risk of VTE in the very high-risk group of elderly acute heart failure patients was 22.014 times that of the high-risk group(95%CI=2.907-166.736,P=0.003).Multivariate logistic regression analysis showed that bed rest for more than 3 days(OR=7.000,95%CI=2.515-19.483,P=0.001),abnormal lung function(OR=3.678,95%CI=1.014-13.346,P=0.048)and high D-dimer value(OR=1.001,95%CI=1.000-1.002,P=0.019)were the independent predictors of the risk of VTE in elderly patients with acute heart failure.Conclusion The Caprini risk assessment model can be effectively used to assess the risk of VTE in elderly patients with acute heart failure.
作者 周迎 任利辉 陈策 彭建军 Zhou Ying;Ren Lihui;Chen Ce;Peng Jianjun(Department of Cardiology,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China)
出处 《中国血管外科杂志(电子版)》 2022年第4期343-347,共5页 Chinese Journal of Vascular Surgery(Electronic Version)
基金 首都医科大学附属北京世纪坛医院院青年基金项目(2017-q26)。
关键词 老年 心力衰竭 静脉血栓栓塞 风险评估 Elderly Heart failure Venous thromboembolism Risk assessment
  • 相关文献

参考文献6

二级参考文献42

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2王美堂,霍正禄,周彬,曹晖,衣月玲.483例静脉血栓栓塞症临床资料分析[J].中国急救医学,2005,25(5):330-332. 被引量:23
  • 3Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation [J ]. J Am Coll Cardiol, 2009, 53(15):e1.
  • 4Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial [ J ]. Circulation, 2009,119 (12) : 1616.
  • 5Cleland J G, Findlay I, Jafri S, et al. The Warfarin/ Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure[J]. Am Heart J,2004,148(1) : 157.
  • 6Cokkinos D V, Haralabopoulos G C, Kostis J B, et al. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study[J]. Eur J Heart Fail,2006, 8(4) :428.
  • 7Avellana P, Segovia J, Ferrero A, et al. Anticoagulation Therapy in Patients With Heart Failure Due to Systolic Dysfunction and Sinus Rhythm: Analysis of REDINSCOR Registry [J]. Rev Esp Cardiol, 2012,65 ( 8 ) : 705.
  • 8Homma S, Thompson J L, Pullicino P M, et al. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm[J]. N Engl J Med,2012,336(20) : 1859.
  • 9Marian Mujjb, MPH Ahmed, Feller MPH, et al. Warfarin Use and Outcomes in Patiets With Advanced Chronic Systolic Heart Failure Without Atrial Fibrillation, Prior Thromboembolic Events, or Prosthetic Values[J]. Am J Cardiol, 201 l, 107 : 552.
  • 10Bettari L, Fiuzat M, Becker R, et al. Thromboembolism and antithrombotic therapy in patients with heart failure in sinus rhythm: current status and future directions[J]. Circ Heart Fail,2011,4(3) :361.

共引文献5989

同被引文献62

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部